Morning Overview on MSN
Study points to long-lived lung B cells as key to stronger flu defense
Every flu season, injectable vaccines prime the immune system to produce antibodies that circulate through the bloodstream.
A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...
Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results